Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 346

1.

Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI).

Malm H, Artama M, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague I, Sourander A.

BMC Psychiatry. 2012 Dec 4;12:217. doi: 10.1186/1471-244X-12-217.

2.

Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.

Brown AS, Gyllenberg D, Malm H, McKeague IW, Hinkka-Yli-Salomäki S, Artama M, Gissler M, Cheslack-Postava K, Weissman MM, Gingrich JA, Sourander A.

JAMA Psychiatry. 2016 Nov 1;73(11):1163-1170. doi: 10.1001/jamapsychiatry.2016.2594.

PMID:
27732704
3.

Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.

Malm H, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague IW, Weissman M, Wickramaratne P, Artama M, Gingrich JA, Sourander A.

J Am Acad Child Adolesc Psychiatry. 2016 May;55(5):359-66. doi: 10.1016/j.jaac.2016.02.013. Epub 2016 Mar 3.

4.

Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data.

Malm H, Sourander A, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague IW, Artama M, Brown AS.

Am J Psychiatry. 2015 Dec;172(12):1224-32. doi: 10.1176/appi.ajp.2015.14121575. Epub 2015 Aug 4.

PMID:
26238606
6.

Risks associated with selective serotonin reuptake inhibitors in pregnancy.

Malm H, Klaukka T, Neuvonen PJ.

Obstet Gynecol. 2005 Dec;106(6):1289-96.

PMID:
16319254
7.

Prenatal smoking exposure and the risk of psychiatric morbidity into young adulthood.

Ekblad M, Gissler M, Lehtonen L, Korkeila J.

Arch Gen Psychiatry. 2010 Aug;67(8):841-9. doi: 10.1001/archgenpsychiatry.2010.92.

PMID:
20679592
8.

Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.

Handal M, Skurtveit S, Furu K, Hernandez-Diaz S, Skovlund E, Nystad W, Selmer R.

BJOG. 2016 Nov;123(12):1908-1917. doi: 10.1111/1471-0528.13582. Epub 2015 Sep 15.

9.

Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.

Grzeskowiak LE, Gilbert AL, Sørensen TI, Olsen J, Sørensen HT, Pedersen LH, Morrison JL.

Ann Epidemiol. 2013 Nov;23(11):681-7. doi: 10.1016/j.annepidem.2013.08.005. Epub 2013 Oct 7.

PMID:
24113367
10.

Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.

Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.

Am J Psychiatry. 2012 Nov;169(11):1165-74. doi: 10.1176/appi.ajp.2012.11111721.

PMID:
23128923
11.

Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.

Grzeskowiak LE, Gilbert AL, Morrison JL.

J Clin Psychopharmacol. 2012 Oct;32(5):615-21. doi: 10.1097/JCP.0b013e31826686bc.

PMID:
22926594
12.

Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.

Colvin L, Slack-Smith L, Stanley FJ, Bower C.

CNS Drugs. 2012 Jul 1;26(7):e1-14. doi: 10.2165/11634190-000000000-00000.

13.

Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

Bakker MK, Kölling P, van den Berg PB, de Walle HE, de Jong van den Berg LT.

Br J Clin Pharmacol. 2008 Apr;65(4):600-6. Epub 2007 Oct 22.

14.

Prenatal antidepressant exposure and the risk of autism spectrum disorders in children. Are we looking at the fall of Gods?

Gentile S.

J Affect Disord. 2015 Aug 15;182:132-7. doi: 10.1016/j.jad.2015.04.048. Epub 2015 May 6. Review.

PMID:
25985383
15.

Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.

Knickmeyer RC, Meltzer-Brody S, Woolson S, Hamer RM, Smith JK, Lury K, Gilmore JH.

Neuropsychopharmacology. 2014 Oct;39(11):2611-21. doi: 10.1038/npp.2014.114. Epub 2014 May 20.

16.

No association between prenatal exposure to psychotropics and intelligence at age five.

Eriksen HL, Kesmodel US, Pedersen LH, Mortensen EL.

Acta Obstet Gynecol Scand. 2015 May;94(5):501-7. doi: 10.1111/aogs.12611. Epub 2015 Mar 17.

PMID:
25711407
17.
18.

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.

Arch Gen Psychiatry. 2006 Aug;63(8):898-906.

PMID:
16894066
19.

Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.

Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, Valdimarsdottir UA, Zoega H, Artama M, Gissler M, Malm H, Nørgaard M.

BMJ. 2015 Apr 17;350:h1798. doi: 10.1136/bmj.h1798. Erratum in: BMJ. 2015;350:h2235.

20.

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.

Eke AC, Saccone G, Berghella V.

BJOG. 2016 Nov;123(12):1900-1907. doi: 10.1111/1471-0528.14144. Epub 2016 May 30. Review.

Supplemental Content

Support Center